Amarin Corp Plc (AMRN)

[Biobillionair]

REDUCE-IT Advisory Docket is open to comment...Amarin has chosen to turn a blind eye to the at risk diabetic population I believe this decision was made at the level of the board of directors, keep this in mind if your love one drops dead in the next 3 months and should have been on Vascepa.

I think this is a terrible strategy for Amarin but there's nothing one person can do to change the pathway decided by the Amarin Board of Directors.

If you have someone that dies or has a CVE and this individual is a type 2 diabetic that was refused a prescription of Vascepa...you may have a wrongful death suit against Amarin board of directors, make sure you name every single board member in this law suit. The FDA has immunity for disregarding standards of care, Amarin Board of Directors do not! This board has the advice of specialty physicians that could have predicted your loved ones death. The Board of Directors has had several regulatory pathways that could have been taken to communicate this issue to the FDA; instead they chose to remain silent for unknown business reasons. The FDA has delayed a priority review PDUFA date by 3 months without Amarin communication of major amendments or other clinical trial deficiencies. The actions by Amarin Board are negligence that has likely led to your love ones demise.

https://www.regulations.gov/document?D=FDA-2019-N-3936-0001

Again...I'm back to Amarin must sell to a competent BP for the sake of patient care.

BB